• Aimei Health Technology received a Nasdaq deficiency notice tied to a late filing of its Form 10-Q for the quarter ended March 31, 2026, which was due May 15.
• The notice cited non-compliance with Nasdaq Listing Rule 5250(c)(1) on timely periodic reporting.
• No immediate impact on trading, but continued non-compliance could lead to delisting.
• The company has 60 calendar days from May 19 to file the report or submit a compliance plan; an accepted plan could extend the deadline to as long as 180 calendar days from the due date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605201605PRIMZONEFULLFEED9723959) on May 20, 2026, and is solely responsible for the information contained therein.